MentalHealthDaily

Belsomra (Suvorexant) Side Effects & Adverse Reactions

Belsomra (Suvorexant) is a drug that was approved by the FDA in 2014 for the treatment of insomnia. It didn’t hit the market until 2015 and is regarded as the first of a new generation of sleeping pills called “orexin receptor antagonists.” Belsomra functions by binding to orexin (hypocretin) receptors OX1 and OX2 to inhibit …

New Sleeping Pills (2015): Orexin Receptor Antagonists

by GLOOM

Some sources estimate that nearly 60 million Americans have difficulties falling asleep a.k.a. a condition known as insomnia. There are many causes of insomnia, including circadian rhythm disturbances, poor diet, inadequate or excessive exercise, high stress, drugs, overworking, and mental illness. In many cases, insomnia can lead to deficiencies in both sleep quality and quantity. …